当前位置: X-MOL 学术Eur. J. Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Response to Finsterer and colleagues on 'Prospective studies on the efficacy of rituximab for myasthenia gravis are warranted'.
European Journal of Neurology ( IF 5.1 ) Pub Date : 2020-08-03 , DOI: 10.1111/ene.14460
A Dos Santos 1 , Y Pereon 2 , S Wiertlewski 1, 2 , A Magot 2
Affiliation  

We thank Dr Finsterer and his colleagues for their interest in our paper (1) and for raising questions about it (2).

中文翻译:

对Finsterer及其同事的答复是“有必要对利妥昔单抗治疗重症肌无力的疗效进行前瞻性研究”。

我们感谢Finsterer博士及其同事对我们的论文(1)感兴趣,并对本文提出了疑问(2)。
更新日期:2020-08-04
down
wechat
bug